Work

In vitro combinations containing Tegobuvir are highly efficient in curing cells from HCV replicon and in delaying/preventing the development of drug resistance

Year: 2015

Type: article

Source: Antiviral Research

DOI: 10.1016/j.antiviral.2015.05.011

Authors: Inge Vliegen, Jan Paeshuyse, Weidong Zhong, Johan Neyts

Institutions: Rega Institute for Medical Research, Gilead Sciences (United States)

Language: English

Topic: Hepatitis C virus research

Subfield: Hepatology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: green

OpenAlex ID: W431802077

FWCI: 0.395

Cites: 25

Cited by: 9

Related to: 10